IHC for pan-TRK proteins may serve as a cost-effective screening tool, though confirmatory NGS is advised in positive cases due to potential false positives, especially in GI tumors with physiological TRK expression [125]. The gene discussed is NTRK1; the disease is digestive system neoplasm.